ask="24.50"
ask_size="100"
average_daily_volume="102090"
bid="N/A"
bid_size="N/A"
book_value="3.21"
change="+0.25"
change_from_200_day_moving_average="-2.86"
change_from_50_day_moving_average="0.42"
change_from_52_week_high="-11.45"
change_From_52_week_low="1.75"
change_in_percent="+4.17%"
close="6.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.49"
ebitda="-19.00M"
eps_estimate_current_year="-3.31"
eps_estimate_next_quarter="-0.88"
eps_estimate_next_year="-3.58"
ex_dividend_date="N/A"
float_shares="6447000"
high="6.40"
high_52_weeks="17.70"
last_trade_date="3/15/2017"
last_trade_price="6.25"
last_trade_size="100"
last_trade_time="4:00pm"
low="5.90"
low_52_weeks="4.50"
market_capitalization="48.86M"
moving_average_200_day="9.11"
moving_average_50_day="5.83"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.64"
open="6.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-31.42%"
percent_change_from_50_day_moving_average="+7.26%"
percent_change_from_52_week_high="-64.69%"
percent_change_from_52_week_low="+38.89%"
previous_close="6.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.87"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.53"
stock_exchange="NCM"
symbol="TRIL"
volume="86642"
weeks_range_52="4.50 - 17.70"
